Meanwhile GSK's lead inhalers include Trelegy Ellipta, projected to bring $3.3bn in 2024 sales, followed by Relvar/Breo Ellipta and Seretide/Advair GlobalData is the parent company of Medical ...
is behind its three licensed inhalers Anoro Ellipta, Relvar Ellipta and Incruse Ellipta. Initial collaboration will combine Propeller’s sensor with Vectura’s lever-operated dry powder inhaler ...
Having begun working together in December 2015, the partners are now ready to bring to market their custom digital sensor for GSK’s asthma and COPD inhaler, Ellipta. The sensor attaches to the ...